Latest News

Targeted radiation plus systemic therapy combo shows promise in mHSPC
Targeted radiation plus systemic therapy combo shows promise in mHSPC

March 18th 2024

"The combination of highly potent systemic therapy and targeted radiation has shown impressive results in maintaining low PSA levels after testosterone recovery, offering hope for improved outcomes in these patients, but further studies are still needed to determine the best regimen," says Amar U. Kishan, MD.

Multi-dose phase of 64Cu/67Cu-SAR-bisPSMA study begins in mCRPC
Multi-dose phase of 64Cu/67Cu-SAR-bisPSMA study begins in mCRPC

March 18th 2024

Phase 3 CELLEBRATE trial testing regenerative stem cell-based therapy to improve urinary control for women
Phase 3 CELLEBRATE trial testing regenerative stem cell-based therapy to improve urinary control for women

March 16th 2024

Study progresses of KVA12123 in solid tumors, including renal cell carcinoma
Study progresses of KVA12123 in solid tumors, including renal cell carcinoma

March 15th 2024

FDA approval sought for UGN-102 for low-grade intermediate-risk NMIBC
FDA approval sought for UGN-102 for low-grade intermediate-risk NMIBC

March 15th 2024

Latest Videos

Latest News

© 2024 MJH Life Sciences

All rights reserved.